First Foundation Advisors’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-14,803
Closed -$339K 349
2025
Q1
$339K Buy
+14,803
New +$357K 0.01% 258
2024
Q2
Sell
-55,111
Closed -$1.66M 447
2024
Q1
$1.66M Sell
55,111
-38,552
-41% -$1.07M 0.07% 132
2023
Q4
$2.68M Sell
93,663
-379,223
-80% -$11.1M 0.12% 99
2023
Q3
$17.5M Sell
472,886
-68,552
-13% -$2.62M 0.82% 32
2023
Q2
$21.1M Sell
541,438
-45,761
-8% -$1.79M 0.91% 25
2023
Q1
$21.4M Buy
587,199
+212,117
+57% +$6.7M 0.99% 23
2022
Q4
$11.6M Buy
+375,082
New +$11.6M 0.55% 48

Other funds holding RTO

First Foundation Advisors's RTO Position: Q2 2025 in Review

First Foundation Advisors sold out of Rentokil (RTO) in Q2 2025, closing a stake of 14,803 shares — an estimated $339K sold.

First Foundation Advisors first reported a position in RTO in Q4 2022 and held it in 7 quarters. The position peaked at $21.4M in Q1 2023. 205 funds tracked by Wall St. Rank hold RTO as of Q2 2025.

  • First Foundation Advisors reported no remaining Rentokil position as of Q2 2025 after selling out during the quarter.
  • First Foundation Advisors sold 14,803 Rentokil shares in Q2 2025, an estimated $339K.
  • First Foundation Advisors first reported a position in Rentokil in Q4 2022 and held it in 7 quarters.
  • First Foundation Advisors's Rentokil position peaked at $21.4M in Q1 2023.
  • 205 funds tracked by Wall St. Rank held Rentokil as of Q2 2025.

Based on First Foundation Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.